Heuking expands Life Sciences practice with team from Taylor Wessing
HEUKING is significantly expanding its Health Care & Life Sciences practice with the addition of three new Equity Partners at its Munich office. Dr. Manja Epping, Dr. Stefanie Greifeneder, and Dr. Sonja Ackermann will join the firm by the beginning of 2026 at the latest, bringing with them a team of Associates. The group is joining from Taylor Wessing and will strengthen HEUKING’s advisory capabilities in the pharmaceutical, biotech, and medical device sectors.
Dr. Manja Epping and Dr. Stefanie Greifeneder focus on regulatory matters and contractual issues relating to clinical trials, marketing authorizations and certifications, as well as the manufacture and distribution of pharmaceuticals and medical devices. Their practice also includes advising on complex licensing agreements and R&D collaborations that are typical within the life sciences industry, along with regulatory aspects of M&A transactions. Stefanie Greifeneder brings additional expertise in supporting spin-offs and start-ups in the biotech and MedTech sectors. Manja Epping has a strong focus on litigation at the intersection of regulatory and intellectual property law.
Dr. Sonja Ackermann is currently a Salary Partner in the Commercial department, with a focus on advising clients in the life sciences sector. She supports national and international companies in drafting and implementing contract manufacturing, procurement, and sales agreements, as well as structuring distribution systems and commercial transactions. Her expertise includes general terms and conditions, e-commerce, and setting up commercial agent and authorized distributor models. Another key area of her work is advising on mobility services and leasing structures in both B2B and B2C contexts.
“The team led by the three Equity Partners brings a sharp focus to the life sciences sector, particularly in the areas of pharmaceuticals, biotech, and medical devices, and demonstrates outstanding industry expertise. Their arrival enhances our advisory capabilities and enables us to offer even more specialized support in M&A transactions and venture capital financing within the life sciences space,” said Boris Dürr, managing partner at HEUKING. “With their strong life sciences expertise and deep understanding of the market, the team led by Dr. Manja Epping, Dr. Stefanie Greifeneder, and Dr. Sonja Ackermann will be a perfect fit for our very well-established practice,” added Dr. Oliver Treptow, who co-leads HEUKING’s Health Care & Life Sciences practice group alongside Dr. Florian Brombach. “Their addition further strengthens our full-service approach across the entire Health Care & Life Sciences sector”.
PICTURED, LEFTO RO RIGHT: Dr. Manja Epping, Dr. Stefanie Greifeneder, and Dr. Sonja Ackermann
